The global mental wellness and consumer neurotechnology market continues to witness rising investor interest as startups increasingly combine neuroscience, artificial intelligence, and wearable technology to build personalised health solutions.Sychedelic has raised $3.5 million, approximately ₹31.5 crore, in a seed funding round led by TurboStart, Ideabaaz, and Praveek Ventures, alongside participation from angel investors across India, the UAE, and the NRI ecosystem.
Based in Gurugram and New York City, the startup was founded by Ria Rustagi and Bhavya. The company is developing what it describes as the world’s first closed-loop neuromodulation wearable built in a headphone-style format for everyday use, positioning itself at the intersection of neurotech, AI-driven wellness, and consumer healthcare.
At the centre of the company’s product ecosystem is a wearable device that combines neurostimulation, biometric sensing, and adaptive artificial intelligence to analyse and respond to users’ mental states in real time. The platform integrates technologies including transcranial direct current stimulation (tDCS), binaural beats, and heart rate variability (HRV) biofeedback to create personalised neuroadaptive experiences focused on reducing stress, improving concentration, enhancing sleep quality, and supporting cognitive wellness.
According to the company, the newly raised capital will be utilised to strengthen marketing initiatives, scale manufacturing operations, expand research and development efforts, and support its upcoming global Kickstarter launch planned for May 2026.
Over the past six months, more than 100 early adopters have reportedly tested the product, enabling the startup to refine its hardware systems, stimulation technology, and AI-powered adaptive algorithms through continuous real-world feedback and usage data.
The company has also achieved a significant regulatory milestone after receiving approval from the Central Drugs Standard Control Organisation, granting the product medical device status in India. In addition, Sychedelic has filed multiple international patent applications that currently remain under patent-pending status.
With operations already established across India and the United States, the startup is now preparing for a broader international expansion as it seeks to strengthen its position within the rapidly evolving neuro-wellness and wearable technology market.
The funding reflects a broader shift within the global healthtech ecosystem, where startups focused on mental wellness, AI-powered healthcare, biometric intelligence, and neurotechnology are increasingly attracting investor attention amid rising consumer demand for proactive and personalised wellness solutions.
